Global Digital Store – Ebooks and Softwares

Tag: Quickly

  • End in sight, but flare-ups likely in the Ebola outbreak in the Democratic Republic of the Congo

    End in sight, but flare-ups likely in the Ebola outbreak in the Democratic Republic of the Congo

    Remarks by Dr Ibrahima Socé Fall, World Health Organization Assistant Director-General, Emergency Response

     

    Good afternoon. 

    I hope that your busy week was interrupted, like mine, with a moment of joy on Tuesday.

    That moment was the celebration of a woman being discharged from an Ebola treatment centre in Beni. Her name is Masiko.

    She was the last person in the Democratic Republic of the Congo confirmed to have Ebola.

    Health workers and other responders sacrificed a lot to get to this point. 

    Since the outbreak was declared in August 2018 there have been 420 attacks on health facilities in DRC, resulting in 11 deaths and 86 injuries among health care workers and patients.

    It’s been a huge amount of work. At the peak of the outbreak, more than 120 cases were being reported each week. 28 health zones were affected, with cases appearing 1200 kilometres apart. In response:

    • 11 labs have been set up to test around 3500 samples each week
    • 11 Ebola treatment centres were set up to care for people with Ebola
    • 300 000 people have been vaccinated
    • 250 000 contacts have been registered
    • 26 000 safe and dignified burials have been conducted
    • More than 3000 health facilities were identified for infection prevention and control support
    • More than 1000 metric tonnes of supplies have been delivered
    • An Ebola vaccine has been licensed, and two treatments found to be highly effective
    • Almost 160 000 million people have been screened for Ebola symptoms at borders or other points of control

    This work is continuing. The outbreak isn’t over. WHO recommends waiting two full incubation periods – that’s 42 days – after the last person tests negative a second time before declaring the end of the outbreak.

    We must stay in active response mode to get us over that finish line.

    We have to be prepared for other cases emerging. It’s is a very real risk.

    Remember that during the Ebola outbreak in West Africa flare-ups of new cases occurred after the end of the outbreak.

    There are four reasons why new cases may emerge during this 42-day period, or even after the end of the outbreak.

    • First, because of the complex security environment, Ebola transmission outside of groups under monitoring is possible.  
    • Second, Ebola virus can persist in used needles, syringes or vials for several weeks.
    • Third, Ebola virus can persist in the body fluids of survivors for many months, and can be transmitted well after recovery, or in rare cases can result in relapse – as we’ve already seen during this outbreak.
    • Finally, Ebola virus is present in an animal reservoir in the region, and there is always a risk of a new spillover to humans.

    This is why it’s critical to maintain surveillance and rapid response capacities.

    And that’s what we are doing. We’re still in full response mode.

    In addition to the activities I already mentioned, I have to underline how critical it is to continue supporting the Survivor Programme, which provides follow-up care for almost all of the 1169 survivors in 26 health areas in North Kivu and Ituri. The programme also helps reduce the risks of re-introduction events. 

    We need to continue this work until the end of the outbreak, to keep the capacity in place to rapidly respond to flare-ups, to keep supporting survivors after the outbreak, and to transition the capacities built in this response toward building a stronger health system. 

    But to be very frank, right now the world risks dropping the baton at the finish line. WHO faces an immediate US $20 million funding gap. If no new resources are received, we will run out of money before the end of the outbreak.

    We appreciate the generosity of donors who have supported the response since August 2018. Now we need to get over the finish line. WHO is calling on the international community to help us end this outbreak, and keep our promises to communities to build a stronger health system.

    If we are forced to scale back operations because of a lack of funds, and then a new case emerges, we might not have the people and resources on the ground that we need to shut down transmission quickly. Just a single case could re-ignite the epidemic.

    That would be a tragedy. An avoidable tragedy. 

    It is important that the global community doesn’t only focus efforts when there is an immediate threat, then walk away when the threat subsides.

    The health system has to be strong to stop much more than Ebola. It has to stop malaria, measles, cholera, and now COVID-19.

    There is a lot more work to do.

    Thank you.

     

    End in sight, but flare-ups likely in the Ebola outbreak in the Democratic Republic of the Congo
    Read More
    https://www.who.int/news-room/detail/06-03-2020-end-in-sight-but-flare-ups-likely-in-the-ebola-outbreak-in-the-democratic-republic-of-the-congo

    Views: 0

  • Computer model of face processing could reveal how the brain produces richly detailed visual representations so quickly

    Computer model of face processing could reveal how the brain produces richly detailed visual representations so quickly

    When we open our eyes, we immediately see our surroundings in great detail. How the brain is able to form these richly detailed representations of the world so quickly is one of the biggest unsolved puzzles in the study of vision.

    Read More

    Views: 0

  • Trade show blues: Exhibitions go virtual as virus spreads

    Trade show blues: Exhibitions go virtual as virus spreads

    Fine wines and hipster gin. Hunting rifles and knives. Contemporary paintings and million-dollar sports cars. They’re all marketed at trade events that are quickly going dark across the globe due to the new coronavirus – and taking with them sales opportunities that may be difficult to make up.

    Read More

    Views: 0

  • Shortage of personal protective equipment endangering health workers worldwide

    WHO calls on industry and governments to increase manufacturing by 40 per cent to meet rising global demand

    The World Health Organization has warned that severe and mounting disruption to the global supply of personal protective equipment (PPE) – caused by rising demand, panic buying, hoarding and misuse – is putting lives at risk from the new coronavirus and other infectious diseases.

    Healthcare workers rely on personal protective equipment to protect themselves and their patients from being infected and infecting others.

    But shortages are leaving doctors, nurses and other frontline workers dangerously ill-equipped to care for COVID-19 patients, due to limited access to supplies such as gloves, medical masks, respirators, goggles, face shields, gowns, and aprons.

    “Without secure supply chains, the risk to healthcare workers around the world is real. Industry and governments must act quickly to boost supply, ease export restrictions and put measures in place to stop speculation and hoarding. We can’t stop COVID-19 without protecting health workers first,” said WHO Director-General Dr Tedros Adhanom Ghebreyesus.

    Since the start of the COVID-19 outbreak, prices have surged. Surgical masks have seen a sixfold increase, N95 respirators have trebled and gowns have doubled.

    Supplies can take months to deliver and market manipulation is widespread, with stocks frequently sold to the highest bidder.

    WHO has so far shipped nearly half a million sets of personal protective equipment to 47 countries,* but supplies are rapidly depleting.

    Based on WHO modelling, an estimated 89 million medical masks are required for the COVID-19 response each month. For examination gloves, that figure goes up to 76 million, while international demand for goggles stands at 1.6 million per month. 

    Recent WHO guidance calls for the rational and appropriate use of PPE in healthcare settings, and the effective management of supply chains.

    WHO is working with governments, industry and the Pandemic Supply Chain Network to boost production and secure allocations for critically affected and at-risk countries.

    To meet rising global demand, WHO estimates that industry must increase manufacturing by 40 per cent.

    Governments should develop incentives for industry to ramp up production. This includes easing restrictions on the export and distribution of personal protective equipment and other medical supplies. 

    Every day, WHO is providing guidance, supporting secure supply chains, and delivering critical equipment to countries in need.  

     *** 

    NOTE TO EDITORS

    Since the start of the COVID-19 outbreak, countries that have received WHO PPE supplies include:

    • Western Pacific region: Cambodia, Fiji, Kiribati, Lao People’s Democratic Republic, Mongolia, Nauru, Papua New Guinea, Samoa, Solomon Islands, Tonga, Vanuatu and the Philippines
    • Southeast Asia region: Bangladesh, Bhutan, Maldives, Myanmar, Nepal and Timor-Leste
    • Eastern Mediteranean region: Afghanistan, Djibouti, Lebanon, Somalia, Pakistan, Sudan, Jordan, Morocco and Iran
    • Africa region: Senegal, Algeria, Ethiopia, Togo, Ivory Coast, Mauritius, Nigeria, Uganda, Tanzania, Angola, Ghana, Kenya, Zambia, Equatorial Guinea, Gambia, Madagascar, Mauritania, Mozambique, Seychelles and Zimbabwe

     

    Read More
    https://www.who.int/news-room/detail/03-03-2020-shortage-of-personal-protective-equipment-endangering-health-workers-worldwide

    Views: 0

  • WHO and FIND formalize strategic collaboration to drive universal access to essential diagnostics

    Geneva, Switzerland – 10 February 2020 – The World Health Organization (WHO) and the Foundation for Innovative New Diagnostics (FIND) announced today that a memorandum of understanding has been signed by the two organizations to formalize a strategic collaboration that will strengthen diagnosis in resource-poor countries by closing major diagnostic gaps at country level and bolstering disease surveillance that will inform public health initiatives and enhance outbreak preparedness and response.

    “This collaboration is an inspiring development that will take us a long way towards ensuring access to diagnostics to all who need them,” said Dr Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization. “Global health challenges such as the ongoing novel coronavirus (2019-nCoV) outbreak demonstrates that without these essential elements of health systems, we cannot hope to promote health, keep the world safe, and serve the vulnerable. I look forward to working closely with FIND to determine what countries need and to forge a path to deliver these innovations so that no one is left behind.”

    Diagnosis is a driver of patient, financial and health systems impact, and a critical enabler of universal health coverage, but it is also the weakest link in the care cascade. This is especially true in primary healthcare settings in low- and middle-income countries. A unique and unprecedented opportunity exists to expand the role and impact of diagnostics to fully realize their potential to address major health security threats and evolving disease burdens through technological and digital advances.

    FIND has been an active partner with WHO since 2008 and a WHO Collaborating Centre since 2014, acting in the areas of laboratory strengthening and diagnostic technology evaluation. This expanded collaboration will put in place the building blocks necessary to enable transformative change in a move toward a country-led diagnostics alliance. Initial workstreams will focus on demand-driven access to essential diagnostics and the development of national Essential Diagnostics Lists, alongside collection of data that assist the scale up of diagnostics to support low- and middle-income countries on their paths to universal health coverage.

    “Each and every person has the right to a quality, timely diagnosis,” said Catharina Boehme, CEO of FIND. “Comprehensive diagnostic services underpin functional and efficient health systems not only to manage day-to-day healthcare needs, but also to ensure new disease outbreaks can be spotted and contained quickly. Working closely with WHO as part of a country-led alliance, we will strive to ensure that low- and middle-income countries have what they need to develop their own comprehensive, data-driven diagnostic strategies that enable universal health coverage and empower disease surveillance. Our ambition is that all patients, providers and decision-makers have access to the diagnostic solutions needed for optimal health outcomes.”

    The strategic collaboration agreement will initially run for a period of 5 years, until 2025.

    #  #  #

    About FIND

    FIND is a global non-profit organization that drives innovation in the development and delivery of diagnostics to combat major diseases affecting the world’s poorest populations. Our work bridges R&D to access, overcoming scientific barriers to technology development; generating evidence for regulators and policy-makers; addressing market failures; and enabling accelerated uptake and access to diagnostics in low- and middle-income countries (LMICs). Since 2003, we have been instrumental in the development of 24 new diagnostic tools used in 150 LMICs. Over 50 million FIND-supported products have been provided to our target markets since the start of 2015. A WHO Collaborating Centre, we work with more than 200 academic, industry, governmental, and civil society partners worldwide, on over 70 active projects that cross six priority disease areas. FIND is committed to a future in which diagnostics underpin treatment decisions and provide the foundation for disease surveillance, control and prevention. For more information, please visit www.finddx.org

     

    About WHO

    The World Health Organization is the directing and coordinating authority for health within the United Nations system. It is responsible for providing leadership on global health matters, shaping the health research agenda, setting norms and standards, articulating evidence-based policy options, providing technical support to countries and monitoring and assessing health trends. WHO is committed to the enjoyment of the highest attainable standard of health as one of the fundamental rights of every human being without distinction of race, religion, political belief, economic or social condition. WHO’s current global programme of work sets out three interconnected strategic priorities: ensuring healthy lives and well-being for all at all ages; achieving universal health coverage; and addressing health emergencies and promoting healthier populations. These priorities are linked to three ambitious targets, the “triple billion”: one billion more people to benefit from universal health coverage; one billion more people better protected from health emergencies; and one billion more people enjoying better health and well-being.

     

    Read More
    https://www.who.int/news-room/detail/10-02-2020-who-and-find-formalize-strategic-collaboration-to-drive-universal-access-to-essential-diagnostics

    Views: 0

  • Online training as a weapon to fight the new coronavirus

    More than 25 000 people across the globe have accessed real-time knowledge from WHO experts on how to detect, prevent, respond to and control the new coronavirus in the 10 days since the launch of an open online training.

    The learning team of the WHO Health Emergencies Programme worked with technical experts to quickly develop and publish the online course on 26 January – 4 days before the 2019-nCoV outbreak was declared a public health emergency of international concern.

    Approximately 3000 new users have registered for the training every day since its launch, demonstrating the high level of interest in the virus among health professionals and the general public. In addition, more than 200 000 people have viewed the introductory video to the course on YouTube.

    The high engagement levels emerged as the international community launched a US$675 million preparedness and response plan to fight further spread of the new coronavirus and protect states with weaker health systems.

    The free learning resource is available to anyone interested in novel coronavirus on WHO’s open learning platform for emergencies, OpenWHO.org. The platform was established 3 years ago with emergencies such as nCoV in mind, in which WHO would need to reach millions of people across the globe with real-time, accessible learning materials.

    The online training – entitled “Emerging respiratory viruses, including nCoV: methods for detection, prevention, response and control” – is currently being produced in all official UN languages and Portuguese.

    “Our job is to work with technical health experts to package knowledge using adult learning principles, quickly so that it is most useful to health workers and our staff,” said Heini Utunen, who manages OpenWHO for the WHO Health Emergencies Programme (WHE). “Our online platform – OpenWHO – is already accessed by users from every country on earth, providing more than 60 courses in 21 languages. Delivering trainings in the local language of responders is really important, especially in an emergency”.    

    WHE has been investing in learning and training to strengthen preparedness and real-time response to health emergencies. The programme developed its first-ever learning strategy in 2018 and has a small dedicated Learning and Capacity Development Unit that allows WHE to develop trainings quickly and get know-how to those who most need it at the front line.  

    For the latest information on the new coronavirus, visit the 2019-nCoV page.

    Read More
    https://www.who.int/news-room/detail/07-02-2020-online-training-as-a-weapon-to-fight-the-new-coronavirus

    Views: 0

  • WHO to accelerate research and innovation for new coronavirus

    WHO to accelerate research and innovation for new coronavirus

    WHO is convening a global research and innovation forum to mobilize international action in response to the new coronavirus (2019-nCoV). 
    “Harnessing the power of science is critical for bringing this outbreak under control,” said WHO Director-General Dr Tedros Adhanom Ghebreyesus. “There are questions we need answers to, and tools we need developed as quickly as possible. WHO is playing an important coordinating role by bringing the scientific community together to identify research priorities and accelerate progress.”
    The forum, to be held 11-12 February in Geneva, is organized in collaboration with the Global Research Collaboration for Infectious Disease Preparedness.
    The forum will bring together key players including leading scientists as well as public health agencies, ministries of health and research funders pursuing 2019-nCoV critical animal health and public health research and the development of vaccines, therapeutics and diagnostics, among other innovations. 
    Participants will discuss several areas of research, including identifying the source of the virus as well as sharing of biological samples and genetic sequences.
     
    Experts will build on existing SARS and MERS coronavirus research and identify knowledge gaps and research priorities in order to accelerate scientific information and medical products most needed to minimize the impact of the 2019-nCoV outbreak.  
    The meeting is expected to produce a global research agenda for the new coronavirus, setting priorities and frameworks that can guide which projects are undertaken first. “Understanding the disease, its reservoirs, transmission and clinical severity and then developing effective counter-measures is critical for the control of the outbreak, to reduce deaths and minimize the economic impact,” said Dr. Soumya Swaminathan, WHO Chief Scientist.
    This will also fast-track the development and evaluation of effective diagnostic tests, vaccines and medicines, while establishing mechanisms for affordable access to vulnerable populations and facilitating community engagement.
    “The WHO R&D Blueprint is a global strategy and preparedness platform that drives coordinated development of drugs and vaccines before epidemics, and allows the rapid activation of R&D activities during epidemics. It speeds up the availability of the diagnostics, vaccines and treatments and technologies that ultimately save lives,” added Dr Michael Ryan, Executive Director, WHO Health Emergencies Programme.  
    Setting clear global research priorities for the novel coronavirus should lead to more efficient investments, high-quality research and synergies among global researchers.

    WHO to accelerate research and innovation for new coronavirus
    Read More
    https://www.who.int/news-room/detail/06-02-2020-who-to-accelerate-research-and-innovation-for-new-coronavirus

    Views: 0

  • How to Write Technically for the Lay Person

    [ad_1]

    While you are writing a book or for a specific magazine or article site, you must be using flowery language using striking words, long sentences, phrases or idioms. In short, you need all those elements that will make the text more catchy and will hook the readers! However, that is not the case in technical writing, i.e. when you are writing for websites that are services or products based. Built using advanced web development frameworks, they need to be produced with clean and simple content that is conversational to the buyers. Specifically, the web content must be representative of the services and the company. But, why called technical writing? A good content on the websites plays a great part in SEO and content marketing. It helps in getting the backlinks and scale up in position of the websites in the search engines to get more visitors.

    So, the next time you are preparing content for a high-end website or online application for your business, keep these tips in mind.

    #1 Know your target audience

    The first thing you need clear-off in your head is the target audience of your site. Be it a group of businessmen or corporate services clients, they are all layman! So, keep your vocabulary outright simple. Don’t use more of technical words and flowery English to make the content snappy. Instead, keep it outright simple, such that even a kid can understand what you provide from your site.

    #2 Show but don’t dictate

    Do not dictate or describe everything about your products or services to the visitors in text. Let them discover that gradually as they proceed to different pages. It makes the visitors curious and persuades them to visit more pages of your site in a session. Thus, show them what you provide, but don’t spell it.

    #3 Use simple, short sentences and active voice

    There is actually no point in over-elaborating technical stuff in the websites. Most visitors are basically skimmers and like to wrap up things quickly. So, try using shorter and simple sentences. And, also use active voice as it’s like you are directly interacting with them.

    #4 Be assertive

    Do not assume that everyone knows about your company, products or services. They don’t. But, they are coming to your site to know about it. So, write with absolute authority and command.

    #5 Avoid the jargon

    Your website is for the layman. Not only for the technically skilled ones! Be sure you are putting information that is also easily understandable by the non-specialists. Even if you need to use complex, technical or niche terms, explain them or hyperlink them to other pages that will give their basic information.

    #6 Use text to compliment the images

    While you will be putting images at every relevant point or pages on the website, create content that will perfectly compliment them. This will enhance the visuals of the site and make it more captivating for the readers.

    These explain web development just do not end with creating a great website or application. But, developers need to have some online content marketing ideas too. They have to know well what exactly can fetch a good amount of visitors to a website, besides making it design-wise attractive.

    [ad_2]

    Source by Rob Stephen

    Views: 0

  • Businesses Pursuing New Product Development

    [ad_1]

    With the aftermath of globalization, companies are carefully thinking about the best ways to extend their product and service offering. Thus, product development strategy is critical for their success. Yet, many companies are in defensive mode and merely want to maintain the position in the market place.

    However, staying in a holding position is a definite way for companies to be left behind. Innovative thinking that allows for product/service growth is a too sure way for sustainable success. In today’s discussion, we will explore the importance of product development for the growth of businesses, especially in a competitive market.

    Launching into new product offerings is not easy. According to one market research, approximately 75% of consumer-packaged goods and retail products fail to earn even $7.5 million during their first year. Harvard Business School Professor, Clayton Christensen, who is the world’s foremost authority on disruptive innovation, suggests that the failure rate of new products may actually be as high as 95%. Product failure rates relate to the number of products that are launched commercially but fail.

    Geoffrey A. Moore, the author of Crossing the Chasm, maintains the challenges of product deployment: “… the less successful product is often arguably superior. No content to slink off the stage without some revenge, this sullen and resentful crew casts about among themselves to find a scapegoat, and whom do they light upon? With unfailing consistency and unerring accuracy, all fingers point to-the vice president of marketing. It is marketing’s fault!” Thus, new product development is a risky proposition to senior executives making these critical positions as well as the organization as a whole.

    Businesses that want sustainable growth must develop new product and services often and consistently. Philip Kotler and Kevin Keller, authors of Marketing Management, “In an economy of rapid change, continuous innovation is a necessity. Highly innovative firms are able to identify and quickly seize new market opportunities.”

    In taking any actions on new product development, businesses should think strategically about their product development. Alexander Chernev, the author of Strategic Marketing Management, further argues that managing growth is the most preferred route to profitability compared to just cutting cost.

    He outlines four key issues in managing growth, which include: (a) gaining and defending a market position, (b) managing sales growth, (c) new product development, and (d) product-line management. Chernev maintains, “New products and services are the keys to sustainable growth; they enable companies to gain and sustain their market position by taking advantage of the changes in the market to create superior customer value.”

    With that said, new product development meaning having the ability to take a product or service idea and convert it into a tangible offering that customers want. The following are the steps that more products undergo for market consumption: (a) idea generation, (b) concept development, (c) business analysis, (d) product development, (e) market testing, and (f) business deployment.

    The Ansoff Matrix is a strategic tool for product development, consisting of market penetration, market development, product development, and diversification. In market penetration strategy, organizations seek to grow using its existing product offerings in existing markets. With this strategy in mind, organizations try to increase market share. In a market development strategy, companies try to expand into new markets like new buyers using their existing offerings. In product development strategy, businesses seek to create new products and services targeted at its existing buyers.

    In a diversification strategy, an organization tries to grow its market share by introducing new product offerings while at the same time entering a new market. Diversification is the most-risky approach due to simultaneous making new changes (new product, new market). Kotler and Keller further maintain the difficulty of sustainable product success: “It is increasingly difficult to identify blockbuster products that will transform a market, but continuous innovation can force competitors to play catch-up.” The concept sounds easy. However, it is riddled with problems.

    Without a doubt, many companies know that product development is a risky business. Although many consumers will proudly proclaim the success of many innovative products like Apple and Google, these same buyers are not aware of the numerous product launch failures in this country. In our discussion, I demonstrated the importance of product development for the growth of businesses, especially in a competitive market. Failures often lead to innovation.

    American great inventor, Thomas Edison, had his own share of failures, but learned how to innovate because of them: “I have not failed. I’ve just found 10,000 ways that won’t work.” Likewise, today’s businesses can also achieve success if they understand how to deploy their products and services to the marketplace strategically. Although there is enormous danger in failure, there is also the opportunity of unforeseen growth. Don’t wait until it’s too late.

    © 2017 by DD Green

    [ad_2]

    Source by Dr. Daryl D. Green

    Views: 0